Differential TDP-43 interactomes between the cortex and cerebellum in the mouse
Tilly Baldacchino, Steven LynhamiD, Sara TacconelliiD, Caroline A. VanceiD, Jacqueline C. MitchelliD
Abstract
TAR DNA binding protein 43 (TDP-43) is the core pathogenic protein across a spectrum of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) cases, but its pathological deposition shows regional selectivity, with abundant TDP-43 positive aggregates in the frontal cortex and spinal cord, and a much lower burden in the cerebellum. In health, TDP-43 expression in the cerebellum is higher than in cortex, hence what underpins this differential vulnerability to TDP-43 aggregation is unclear. Here we demonstrate that in healthy C57Bl/6J mice not only is TDP-43 expression higher in the cerebellum than the cortex, but that this expression difference is driven primarily by differences in cytoplasmic load. Mass spectrometry analysis of TDP-43 pull downs from the cortex and cerebellum of healthy mice identified TDP-43 interactors across a number of core functional pathways, with numerous differences between the two brain regions. Data are available via ProteomeXchange with identifier PXD062532. Notably, there were more interactors identified in both nuclear and cytoplasmic fractions within the cortex than the cerebellum. Putative interactions with four core paraspeckle proteins; SFPQ, NONO, FUS and PSPC1 were confirmed using immunoprecipitation and western blot analysis. Follow up validation using proximity ligation assay showed abundant perinuclear cytoplasmic interactions between TDP-43 and all four paraspeckle proteins in both large motor cortex neurons and purkinje cells, with significantly reduced nuclear interactions detected in the motor cortex for SFPQ, FUS and PSPC1. These findings suggest that TDP-43-protein interactions markedly differ between the TDP-43 pathogenesis vulnerable cortex and relatively resistant cerebellum and exploring these differences may yield new insight into disease mechanisms within ALS/FTD.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Context-dependent Interactors Regulate TDP-43 Dysfunction in ALS/FTLD
Longxin Xie, Yuehua Zhu, … Christopher J. Donnelly·bioRxiv·Apr 7, 2025
- TDP-43 expression in the cytoplasm leads to early synaptic and mitochondrial abnormalities in an inducible mouse model of ALS/FTD
Florencia Vassallu, Milagros López, … Lionel Muller Igaz·Neurochemistry InternationalPeer-reviewed·May 13, 2026
- A functional interaction between TDP-43 and USP10 reveals USP10 dysfunction in TDP-43 proteinopathies
Alessandro Marrero‐Gagliardi, Judith Noda, … Abraham Acevedo‐Arozena·bioRxiv·Jan 23, 2024
- A transient protein folding response targets aggregation in the early phase of TDP-43-mediated disease
Rebecca San Gil, Dana Pascovici, … Adam K. Walker·bioRxiv·Jun 21, 2023
- Amyotrophic lateral sclerosis associated mislocalisation of TDP-43 to the cytoplasm causes cortical hyperexcitability and reduced excitatory neurotransmission in the motor cortex.
Marcus S. Dyer, Laura A. Reale, … Catherine A. Blizzard·Journal of NeurochemistryPeer-reviewed·Oct 16, 2020
- Prion-like C-terminal domain of TDP-43 and α-Synuclein interact synergistically to generate neurotoxic hybrid fibrils
S. Dhakal, C. E. Wyant, … V. Rangachari·bioRxiv·Dec 12, 2020